Diagnostic delay of rare diseases in Europe and in Hungary;A ritka betegségek diagnosztikájának késedelme Európában és Magyarországon

Orvosi Hetilap

Volumn 153, Issue 30, 2012, Pages 1185-1190

  Földvári, Anett ^a   Szy, Ildikó ^b,c   Sándor, János ^a,c,f   Pogány, Gábor ^d   Kosztolányi, György ^c,e  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Egészségpolitikai Foosztály   (Hungary)

^c Orszagos Egeszsegfejlesztesi Intezet   (Hungary)

^d Ritka Es Veleszuletett Rendellenesseggel Elok Orszagos Szovetsege   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

^f NONE   (Hungary)

Author keywords

diagnostic delay; rare diseases

Indexed keywords

CYSTIC FIBROSIS; DIAGNOSTIC ERROR; DUCHENNE MUSCULAR DYSTROPHY; EUROPE; HEALTH SURVEY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; QUESTIONNAIRE; RARE DISEASE; RETINITIS PIGMENTOSA; REVIEW; TUBEROUS SCLEROSIS; WILLIAMS BEUREN SYNDROME;

EID: 84864431034     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2012.29418     Document Type: Review

References (14)

1. McCabe, C., Claxton, K., Tsuchiya, A.: Orphan drugs and the NHS : Should we value rarity? BMJ, 2005, 331, 1016-1019.
2. Schieppati, A., Henter, J. I., Diana, E., et al.: Why rare diseases are an important medical and social issue. Lancet, 2008, 371, 2039-2041.
3. Eurordis (European Organistaion for Rare Diseases): "Rare Diseases : Understanding this Public Health Priority", 2005.
4. Orphanet (The portal for rare diseases and orphan drugs), www. orpha.net
5. Orphanet Report Series (Rare Diseases Collection): Prevalence of rare diseases: Bibliogaphic data. Number 2. 2009.
6. Roll, K.: The infl uence of regional health care structures on delay in diagnosis of rare diseases: The case of Marfan Syndrome. Health Policy, 2012, 105, 119-127.
7. Fragonese, L., Stolk, J.: Hereditary alpha-1-antitrysin defi ciency and its clinical conseqences. Orphanet J. Rare Dis., 2008, 3, 16.
8. Eurordis: The Voice of 12 000 Patients. Experiences and Expectations of Rare Disease Patients on Diagnosis and Care in Europe. Paris, 2009.
9. Skotko, G. B., Kishnani, S. P., Capone, T. G.: Prenatal diagnosis of Down sydrome: How best to deliver the news. Am. J. Med. Genet., 2009, 149(A), 2361-2367.
10. Hungarian Federation of People with Rare and Congenital Diseases - Rare Diseases Hungary: Deliver the diagnosis of rare diseases. Crisis communication of congenital diseases' diagnosis which are : Rare, incurable, and/or chronic, resulted in serious disability and affect mostly children. [Ritka és Veleszületett Rendellenességgel élok Országos Szövetsége: Ritka rendellenességgel élok diagnózisközlésének protokollja. Krí ziskommunikáció ritka, gyógyíthatatlan és/vagy krónikus, leépüléssel járó, általában gyermekeket érinto veleszületett betegség diagnózisának közlésére.] 2011. http://europlan.rirosz.hu/euroterv- iikonferencia- 1/az-elhangzott-eloadasok/Diagnoziskozlesi-protokoll.pdf? attredirects=0&d=1 [Hungarian]
11. Götz, I., Götz, M.: Cystic fi brosis psychologiocal issues. Paediatr. Respir. Rev., 2000, 1, 121-127.
12. Stych, B., Dobrovolny, D.: Familial cold auto-infl ammatory sydrome (FACS) : Characterization of symptomatology and impact on patients' live. Curr. Med. Res. Opin., 2008, 24, 1577-1582.
13. Kole, A., Faurisson, F.: Rare diseases social epidemiology : Analysis of inequalities. In: Rare diseases epidemiology. Eds.: Posanda de la Paz, M., Groft, C. S. Springer, Dordrecht-Heidelberg- London-New York, 2010.
14. Mehta, G., Macek, M. jr., Mehta, A., European Registry Working Group: Cystic fi brosis across Europe: EuroCare analysis of demographic data from 35 countries. J. Cyst. Fibros., 2010, 9 (Suppl. 2), S5-S21.